abstract |
The present invention relates to a series of novel compounds having antiviral activity, more particularly HIV (human immunodeficiency virus) replication inhibiting properties. The invention also relates to methods for the preparation of such compounds, and novel intermediates useful in one or more steps of such synthesis. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. The invention further relates to the use of such compounds as medicaments and the use of such compounds in the manufacture of medicaments useful for the treatment of animals suffering from viral infections, in particular HIV infections. The invention further relates to a method of treating a viral infection in an animal by administration of a therapeutic amount of such a compound that may be combined with one or more other drugs having antiviral activity. [Selection figure] None |